Court overturns patent decision against Johnson & Johnson


WASHINGTON — A US appeals­ court ruled that a Johnson & Johnson heart stent does not infringe on a patent held by a doctor and an inventor, overturning a $482 million verdict against the company. The three-judge panel said a lower court misinterpreted the company’s patent and should not have ruled in favor of Dr. Bruce Saffran­ of Princeton, N.J.

Heart stents are mesh-wire tubes that prop open arteries affected by coronary artery disease. The dispute centered on drug-eluting stents, which release a drug to help keep arteries­ from clogging.

Saffran sued J&J in 2007, alleging its Cypher stents infringed on his 1997 patent covering technology to deliver medication inside the body. A Texas jury ruled in Saffran’s favor in 2011, concluding that J&J had willfully infringed on his patent.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of